MicroPort Endovascular MedTech Ltd Asset Resilience Ratio
MicroPort Endovascular MedTech Ltd asset resilience ratio. MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 18.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688016 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of MicroPort Endovascular MedTech Ltd (2025–2025)
Asset resilience ratio of MicroPort Endovascular MedTech Ltd from 2025 to 2025. This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. Read 688016 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MicroPort Endovascular MedTech Ltd (688016) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥906.83 Million | 18.3% |
| Total Liquid Assets | CN¥906.83 Million | 18.30% |
Asset Resilience Insights
- Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 18.30% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio
Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
MicroPort Endovascular MedTech Ltd Asset Resilience Ratio by Year (2025–2025)
MicroPort Endovascular MedTech Ltd asset resilience ratio by year from 2025 to 2025. The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.16% | CN¥100.37 Million ≈ $14.69 Million |
CN¥4.64 Billion ≈ $679.15 Million |
-- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more